Summary
CVS Health Corporation reported strong performance for the nine months ended September 30, 2015, with net revenues increasing by 9.6% to $112.1 billion. This growth was driven by robust performance in both the Pharmacy Services and Retail/LTC segments, with the latter significantly bolstered by the acquisition of Omnicare, Inc. for approximately $9.6 billion in August 2015. Net income attributable to CVS Health increased by 12.5% to $3.74 billion for the same period, demonstrating effective operational execution and strategic acquisitions. The company also announced a proposed acquisition of Target's pharmacy and clinic businesses for $1.887 billion, indicating continued aggressive growth strategies. The balance sheet reflects substantial increases in goodwill and intangible assets, largely due to the Omnicare acquisition, alongside a significant increase in long-term debt to finance these strategic moves. Operating cash flow remained strong, although investing activities showed a significant outflow due to the acquisition. The company also continued its share repurchase program, returning capital to shareholders. Despite increased debt and integration costs, the financial health of CVS Health appears solid, supported by its diversified business model and strategic acquisitions. Overall, CVS Health demonstrated significant growth and executed major strategic initiatives during this period, positioning itself for continued expansion in the integrated healthcare and pharmacy market. Investors should note the substantial debt taken on to fund acquisitions and the ongoing integration efforts as key factors to monitor.
Financial Highlights
57 data points| Revenue | $38.64B |
| Cost of Revenue | $31.98B |
| Gross Profit | $6.66B |
| Operating Expenses | $4.33B |
| Operating Income | $2.33B |
| Interest Expense | $268.00M |
| Net Income | $1.25B |
| EPS (Basic) | $1.11 |
| EPS (Diluted) | $1.11 |
| Shares Outstanding (Basic) | 1.11B |
| Shares Outstanding (Diluted) | 1.12B |
Key Highlights
- 1Net revenues for the nine months ended September 30, 2015, increased by 9.6% year-over-year to $112.14 billion.
- 2Net income attributable to CVS Health for the nine months ended September 30, 2015, rose by 12.5% to $3.74 billion.
- 3Acquisition of Omnicare, Inc. for approximately $9.6 billion was completed on August 18, 2015, significantly expanding the Retail/LTC segment.
- 4The company announced a proposed acquisition of Target's pharmacy and clinic businesses for $1.887 billion.
- 5Long-term debt increased substantially from $11.63 billion at year-end 2014 to $26.77 billion as of September 30, 2015, primarily due to financing the Omnicare acquisition.
- 6Goodwill increased significantly from $28.14 billion to $37.13 billion, driven by the Omnicare acquisition.
- 7Diluted earnings per share from continuing operations for the nine months ended September 30, 2015, were $3.28, up from $2.82 in the prior year.